Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
A P2P lender for short-term borrowers focused on providing affordable, flexible and ethical loans. Welendus has full FCA authorisation and there are over 18,000 users on the platform with more than 900 loans issued. Investment is sought to expand the team with new operational members and grow the service with the use of viral marketing and referrals. The company is seeking more IP applications and to develop the service with new functionalities.
days to go:
Expired
investment:
£939,104
Sugi is an app that aims to show everyday investors how green their investments are and help them build a greener portfolio via its app. The company asserts that there are over 3 million Do-It-Yourself (DIY) investors in the UK, with over £210 billion of investments and 76% of that number want their investments to have a positive impact. Sugi intends to do just that. Its app combines three key trends namely, ESG investing, Open Finance, and carbon tracking to further green investments. The company has raised £210,000 to date. Sugi connects to a user's existing investment platform, be that an ISA, SIPP, or trading account, and enables them to learn how their investments affect the planet and what they can do to leave an eco-positive impression. Sugi has featured in publications like Reuters, The Times, Good with Money, This is Money, and AltFi, to name a few. Sugi will use the investment to further develop its app, expand its team, and implement its growth strategy.
days to go:
Expired
investment:
£406,157
Bippit is a wellbeing platform that provides employees with financial consultancy from a professional with zero cost to the employees themselves. The company asserts that COVID-19 has made financial consultancy services difficult to access for employees. Bippit aims to resolve this situation. It is available in mobile and desktop formats and integrates with an employees’ entire financial life through 'Open Banking'. Bippit argues that this helps staff members receive all the tools they need to learn, plan, and take action concerning their finances. It also helps companies save time and money, ensures that employees receive an impartial support system, and allows financial experts to get an extra revenue stream. The company will launch an Initial Public Offering (IPO) likely within 5 years if it moves beyond strategic acquisition.
days to go:
Expired
investment:
£73,000
Enoron is a management system that allows lawyers to easily manage all their clients and all their related information, all their matters and deadlines, keeping track of all their activities, timesheets and accounting and much more.
days to go:
Expired
investment:
£31,896
InvestMyCommunity, trading under Karadoo, offers digital fundraising services to 1.5 million community organisations in the UK. The company argues that organisations need to urgently digitise donations they receive in cash each year in the face of rapid cash decline. Karadoo asserts that its digital services solve this situation. The company is Financial Conduct Authority (FCA) authorised, offers donation fundraising, and plans to shortly offer micro-loan and micro-equity options on its platform. Karadoo has invested over £400,000 in highly automated platforms with low risk. It asserts that its hybrid operating model offers easy scalability as well as efficiency. The company claims that the introduction of contactless donation terminals in 2021 will strengthen the company's credibility. Karadoo intends to exit via a trade sale to a competitor or a software provider.
days to go:
Expired
investment:
£200,000
Those who work in services, such as the Armed Forces, can find it difficult to access financial products due to their anomalous credit histories compared to non-services personnel. TSFL aims to address this with their advanced risk-modelling platform for underwriters. This will allow tailored insurance, consumer credit and eventually home lending to be sold through TSFL.
days to go:
Expired
investment:
£1,431,885
